1. Home
  2. KLXE vs CING Comparison

KLXE vs CING Comparison

Compare KLXE & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

HOLD

Current Price

$2.21

Market Cap

39.8M

Sector

Energy

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$5.37

Market Cap

40.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLXE
CING
Founded
2018
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.8M
40.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KLXE
CING
Price
$2.21
$5.37
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$31.33
AVG Volume (30 Days)
238.3K
229.8K
Earning Date
03-11-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$645,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$3.20
52 Week High
$7.40
$6.74

Technical Indicators

Market Signals
Indicator
KLXE
CING
Relative Strength Index (RSI) 58.51 62.79
Support Level $2.01 $4.83
Resistance Level $2.25 $6.74
Average True Range (ATR) 0.20 0.54
MACD -0.01 0.07
Stochastic Oscillator 65.44 45.16

Price Performance

Historical Comparison
KLXE
CING

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: